title: Veterinary and human vaccine evaluation methods.
abstract: Despite the universal importance of vaccines, approaches to human and veterinary vaccine evaluation differ markedly. For human vaccines, vaccine efficacy is the proportion of vaccinated individuals protected by the vaccine against a defined outcome under ideal conditions, whereas for veterinary vaccines the term is used for a range of measures of vaccine protection. The evaluation of vaccine effectiveness, vaccine protection assessed under routine programme conditions, is largely limited to human vaccines. Challenge studies under controlled conditions and sero-conversion studies are widely used when evaluating veterinary vaccines, whereas human vaccines are generally evaluated in terms of protection against natural challenge assessed in trials or post-marketing observational studies. Although challenge studies provide a standardized platform on which to compare different vaccines, they do not capture the variation that occurs under field conditions. Field studies of vaccine effectiveness are needed to assess the performance of a vaccination programme. However, if vaccination is performed without central co-ordination, as is often the case for veterinary vaccines, evaluation will be limited. This paper reviews approaches to veterinary vaccine evaluation in comparison to evaluation methods used for human vaccines. Foot-and-mouth disease has been used to illustrate the veterinary approach. Recommendations are made for standardization of terminology and for rigorous evaluation of veterinary vaccines.
authors.affiliation: The Pirbright Institute, , Pirbright, UK, The Royal Veterinary College (VEEPH), University of London, , London, UK, School of Paediatrics and Child Health (SPACH), The University of Western Australia, , Crawley, Australia.
authors.forename: T J D
authors.initials: TJ
authors.lastname: Knight-Jones
authors.forename: K
authors.initials: K
authors.lastname: Edmond
authors.forename: S
authors.initials: S
authors.lastname: Gubbins
authors.forename: D J
authors.initials: DJ
authors.lastname: Paton
mesh_terms: D000818:Animals; D003140:Communicable Disease Control / Q000379:methods*; D005069:Evaluation Studies as Topic; D006801:Humans; D014611:Vaccination / Q000592:standards*; D014612:Vaccines / Q000008:administration & dosage*; D014730:Veterinary Medicine / Q000379:methods*
chemical_list: D014612:Vaccines
keywords: evaluation; vaccine; vaccine effectiveness; veterinary
references.citation: Epidemiol Rev. 1996;18(2):99-117
references.pmid: 9021306
references.citation: Clin Microbiol Rev. 2007 Jul;20(3):489-510, table of contents
references.pmid: 17630337
references.citation: Lancet. 1986 Aug 30;2(8505):499-502
references.pmid: 2875247
references.citation: JAMA. 1996 Feb 7;275(5):390-7
references.pmid: 8569019
references.citation: PLoS Comput Biol. 2010 Dec 09;6(12):e1001027
references.pmid: 21151576
references.citation: Vaccine. 2012 Sep 21;30(43):6210-5
references.pmid: 22704925
references.citation: Lancet. 1995 Nov 18;346(8986):1339-45
references.pmid: 7475776
references.citation: Vaccine. 2011 Dec 6;29(52):9575-7
references.pmid: 22041303
references.citation: J Epidemiol Community Health. 2011 Jul;65(7):582-7
references.pmid: 19213758
references.citation: Vaccine. 2008 Mar 20;26(13):1681-7
references.pmid: 18313814
references.citation: Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):50-8
references.pmid: 17524495
references.citation: Clin Infect Dis. 2008 Oct 15;47(8):989-96
references.pmid: 18781875
references.citation: Vaccine. 2010 Aug 31;28(38):6128-36
references.pmid: 20655402
references.citation: J Med Ethics. 2004 Feb;30(1):110-6
references.pmid: 14872087
references.citation: Vaccine. 2011 May 12;29(21):3782-90
references.pmid: 21440035
references.citation: Lancet. 2007 Apr 21;369(9570):1356-1362
references.pmid: 17448821
references.citation: Epidemiol Infect. 2008 Nov;136(11):1556-63
references.pmid: 18177524
references.citation: Comp Immunol Microbiol Infect Dis. 2009 Jul;32(4):351-63
references.pmid: 18442853
references.citation: Vaccine. 2001 Oct 15;20 Suppl 1:S58-67
references.pmid: 11587814
references.citation: Clin Infect Dis. 2008 Aug 1;47(3):401-9
references.pmid: 18558875
references.citation: Emerg Infect Dis. 2011 Mar;17(3):379-86
references.pmid: 21392427
references.citation: Vaccine. 2014 Apr 1;32(16):1848-55
references.pmid: 24530150
references.citation: Prev Vet Med. 2013 Nov 1;112(3-4):161-73
references.pmid: 23958457
references.citation: Lancet. 2014 May 17;383(9930):1762-70
references.pmid: 24553294
references.citation: Bull World Health Organ. 1985;63(6):1055-68
references.pmid: 3879673
references.citation: J Virol Methods. 2010 Jun;166(1-2):21-7
references.pmid: 20170683
references.citation: Vaccine. 2012 Jul 13;30(33):4907-20
references.pmid: 22658928
references.citation: Rev Sci Tech. 2005 Dec;24(3):981-93
references.pmid: 16642769
references.citation: Hum Vaccin Immunother. 2012 Jun;8(6):715-24
references.pmid: 22495119
references.citation: J Natl Cancer Inst. 2013 Apr 3;105(7):469-74
references.pmid: 23486550
references.citation: Clin Infect Dis. 2006 Feb 1;42(3):315-9
references.pmid: 16392073
references.citation: Fish Shellfish Immunol. 2011 Jan;30(1):304-8
references.pmid: 21059396
references.citation: J Hyg (Lond). 1966 Mar;64(1):105-20
references.pmid: 5219018
references.citation: BMC Med Res Methodol. 2006 Nov 08;6:54
references.pmid: 17092344
references.citation: Epidemiol Rev. 1988;10:212-41
references.pmid: 3066628
references.citation: Curr Mol Med. 2007 May;7(3):319-25
references.pmid: 17504116
references.citation: Vaccine. 2011 Jul 26;29(33):5467-73
references.pmid: 21640777
references.citation: Expert Rev Vaccines. 2009 Mar;8(3):347-65
references.pmid: 19249976
references.citation: Biologicals. 2011 Mar;39(2):117-28
references.pmid: 21371907